New Drug Controller of India (DCGI) takes over

New Delhi: Dr Eshwar Reddy is the new Drug Controller of India (DCGI). He takes over the charge from Dr G.N. Singh.

Dr Reddy bucks the trend in the sense that he is not a political appointee. He is from within the department and is seized of a well thought out Pharma vision 2030.  Perhaps After a long time, he is a professional appointee as in the past most DCGI were political nominations from outside department. For long term Pharma vision, he is considered the most eligible one for this post.

Dr Reddy has leadership qualities and it is hugely hoped that he would come out with flying colours during his three month probation. Medical device sector has been his pet subject.

Rajiv Nath, Forum Coordinator, Association of Indian Medical device industry (AiMeD), has expressed utmost pleasure on his appointment and not being a political appointee. Dr Reddy was joint drug controller of India.

  • Related Posts

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?